Kun, Y.; Wu, J.; Chen, S. Effects of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) Targeted Combined Chemotherapy on Immune Function, Tumor Markers and Oxidative Stress in Patients With Stage IV Lung Adenocarcinoma. Pak J Med Sci 2023, 39.